Inhibikase Therapeutics, Inc. Common Stock
Symbol: IKT (NASDAQ)
1.57
▲ (1.95%) 0.030
Company Description:
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
Key Stats
- Today's Open: $1.57
- Today's High: $1.57
- Today's Low: $1.57
- Today's Volume: 2.00K
- Yesterday Close: $1.54
- Yesterday High: $1.6425
- Yesterday Low: $1.525
- Yesterday Volume: 107.76K
- Last Min Volume: 2.00K
- Last Min High: $1.57
- Last Min Low: $1.57
- Last Min VWAP: $1.57
Company Profile
- Name: Inhibikase Therapeutics, Inc. Common Stock
- Website: https://www.inhibikase.com
- Listed Date: 2020-12-23
- Location: WILMINGTON, DE
- Market Status: Active
- CIK Number: 0001750149
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $114.76M
- Round Lot: 100
- Outstanding Shares: 74.52M
- Asset Type: CS
RECENT FILINGS FOR IKT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-28 | 3/A | View |
| 2025-08-28 | 3/A | View |
| 2025-08-28 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-07-15 | 3/A | View |
| 2025-07-02 | 4/A | View |
| 2025-07-02 | 4/A | View |
| 2025-07-02 | 4/A | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-27 | EFFECT | View |
| 2025-06-25 | CORRESP | View |
Latest News on IKT